These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31404021)
1. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer. Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Maekawa S; Mochizuki K; Kawaida H; Kono H; Itakura J; Sato T; Ichikawa D; Enomoto N Pancreas; 2019 Sep; 48(8):1032-1040. PubMed ID: 31404021 [TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice. Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Maekawa S; Mochizuki K; Kawaida H; Itakura J; Katoh R; Fujii H; Sato T; Enomoto N Pancreas; 2017; 46(10):1281-1287. PubMed ID: 28930868 [TBL] [Abstract][Full Text] [Related]
3. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers. Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266 [TBL] [Abstract][Full Text] [Related]
4. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant. Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889 [TBL] [Abstract][Full Text] [Related]
5. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing. Kuratomi N; Takano S; Fukasawa M; Maekawa S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Takada H; Nakakuki N; Kato R; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Inoue T; Kondo T; Ichikawa D; Enomoto N Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809988 [TBL] [Abstract][Full Text] [Related]
6. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms. Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845 [TBL] [Abstract][Full Text] [Related]
7. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541 [TBL] [Abstract][Full Text] [Related]
8. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms. Yu J; Sadakari Y; Shindo K; Suenaga M; Brant A; Almario JAN; Borges M; Barkley T; Fesharakizadeh S; Ford M; Hruban RH; Shin EJ; Lennon AM; Canto MI; Goggins M Gut; 2017 Sep; 66(9):1677-1687. PubMed ID: 27432539 [TBL] [Abstract][Full Text] [Related]
9. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation. Takano S; Fukasawa M; Maekawa S; Kadokura M; Miura M; Shindo H; Takahashi E; Sato T; Enomoto N PLoS One; 2014; 9(6):e98718. PubMed ID: 24897499 [TBL] [Abstract][Full Text] [Related]
10. KRAS Mutations With No GNAS Mutations in an Intraductal Papillary Mucinous Neoplasm: Are There Common Pathways With Pancreatic Ductal Adenocarcinoma? Lessons From an Extended IPMN, Covering the Entire Pancreas. Tampakis A; Tampaki EC; Posabella A; Zettl A; Kouraklis G; von Flüe M; Guenin MO Pancreas; 2017 Jan; 46(1):e5-e7. PubMed ID: 27977634 [No Abstract] [Full Text] [Related]
11. Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis. Nissim S; Idos GE; Wu B Pancreas; 2012 Nov; 41(8):1195-205. PubMed ID: 22750975 [TBL] [Abstract][Full Text] [Related]
12. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521 [TBL] [Abstract][Full Text] [Related]
13. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757 [TBL] [Abstract][Full Text] [Related]
14. Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the Pancreas. Matsuzaka S; Karasaki H; Ono Y; Ogata M; Oikawa K; Tamakawa S; Chiba S; Muraki M; Yokochi T; Funakoshi H; Kono T; Nagashima K; Mizukami Y Pancreas; 2016 Jul; 45(6):915-8. PubMed ID: 27295533 [TBL] [Abstract][Full Text] [Related]
15. Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreas. Mateos RN; Nakagawa H; Hirono S; Takano S; Fukasawa M; Yanagisawa A; Yasukawa S; Maejima K; Oku-Sasaki A; Nakano K; Dutta M; Tanaka H; Miyano S; Enomoto N; Yamaue H; Nakai K; Fujita M Cancer Med; 2019 Aug; 8(10):4565-4573. PubMed ID: 31225717 [TBL] [Abstract][Full Text] [Related]
16. Intraductal papillary mucinous neoplasms of the pancreas: Clinical association with KRAS. Chang XY; Wu Y; Li Y; Wang J; Chen J Mol Med Rep; 2018 Jun; 17(6):8061-8068. PubMed ID: 29658583 [TBL] [Abstract][Full Text] [Related]
17. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas. Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395 [TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108 [TBL] [Abstract][Full Text] [Related]
19. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224 [TBL] [Abstract][Full Text] [Related]
20. Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. Mohri D; Asaoka Y; Ijichi H; Miyabayashi K; Kudo Y; Seto M; Ohta M; Tada M; Tanaka Y; Ikenoue T; Tateishi K; Isayama H; Kanai F; Fukushima N; Tada M; Kawabe T; Omata M; Koike K J Gastroenterol; 2012 Feb; 47(2):203-13. PubMed ID: 22041919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]